Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

Clinical trial NCT02220985 · COMPLETED

Trial details

NCT number: NCT02220985
Sponsor: Fred Hutchinson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Allogeneic Hematopoietic Stem Cell Transplant Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Donor Lymphoblastic Lymphoma Myelodysplastic Syndrome With Excess Blasts

Start date: 2015-03-23
Primary completion: 2025-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.